Rossari Biotech Limited (BOM:543213)
687.55
-2.20 (-0.32%)
At close: Apr 16, 2025
Rossari Biotech Statistics
Total Valuation
Rossari Biotech has a market cap or net worth of INR 39.01 billion. The enterprise value is 39.82 billion.
Market Cap | 39.01B |
Enterprise Value | 39.82B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | Aug 16, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.03% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 17.62M |
Valuation Ratios
The trailing PE ratio is 28.67.
PE Ratio | 28.67 |
Forward PE | n/a |
PS Ratio | 1.98 |
PB Ratio | 3.49 |
P/TBV Ratio | 4.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 29.26 |
EV / Sales | 2.02 |
EV / EBITDA | 16.15 |
EV / EBIT | 20.98 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.14 |
Debt / EBITDA | 0.65 |
Debt / FCF | n/a |
Interest Coverage | 11.79 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 9.88% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 43.85M |
Profits Per Employee | 3.02M |
Employee Count | 450 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.05% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -9.05% |
50-Day Moving Average | 646.22 |
200-Day Moving Average | 787.53 |
Relative Strength Index (RSI) | 67.59 |
Average Volume (20 Days) | 5,801 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rossari Biotech had revenue of INR 19.73 billion and earned 1.36 billion in profits. Earnings per share was 24.58.
Revenue | 19.73B |
Gross Profit | 5.96B |
Operating Income | 1.89B |
Pretax Income | 1.83B |
Net Income | 1.36B |
EBITDA | 2.44B |
EBIT | 1.89B |
Earnings Per Share (EPS) | 24.58 |
Balance Sheet
The company has 800.08 million in cash and 1.61 billion in debt, giving a net cash position of -807.73 million.
Cash & Cash Equivalents | 800.08M |
Total Debt | 1.61B |
Net Cash | -807.73M |
Net Cash Per Share | n/a |
Equity (Book Value) | 11.18B |
Book Value Per Share | 202.14 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 30.22%, with operating and profit margins of 9.57% and 6.89%.
Gross Margin | 30.22% |
Operating Margin | 9.57% |
Pretax Margin | 9.28% |
Profit Margin | 6.89% |
EBITDA Margin | 12.38% |
EBIT Margin | 9.57% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.07%.
Dividend Per Share | 0.50 |
Dividend Yield | 0.07% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.03% |
Shareholder Yield | 0.04% |
Earnings Yield | 3.49% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |